Indivior PLC (INDV)
USD 8.85
(-3.33%)
USD 8.85
(-3.33%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 235.66 Million USD | -1.1% |
| 2022 | 238.28 Million USD | -0.11% |
| 2021 | 238.53 Million USD | 3.71% |
| 2020 | 229.99 Million USD | -1.29% |
| 2019 | 233 Million USD | -1.69% |
| 2018 | 236.99 Million USD | -50.31% |
| 2017 | 476.99 Million USD | 9.91% |
| 2016 | 433.99 Million USD | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q3 | 235 Million USD | 0.0% |
| 2024 Q2 | 235.03 Million USD | 0.08% |
| 2024 Q1 | 234.82 Million USD | -0.36% |
| 2023 FY | 235.66 Million USD | -1.1% |
| 2023 Q4 | 235.66 Million USD | -0.07% |
| 2023 Q3 | 235.83 Million USD | 0.09% |
| 2023 Q2 | 235.61 Million USD | 0.09% |
| 2023 Q1 | 235.39 Million USD | -1.21% |
| 2022 Q1 | 237.39 Million USD | -0.48% |
| 2022 Q2 | 237.51 Million USD | 0.05% |
| 2022 Q3 | 236.93 Million USD | -0.24% |
| 2022 Q4 | 238.28 Million USD | 0.57% |
| 2021 Q4 | 238.53 Million USD | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| Cosmos Health Inc. | 3.03 Million USD | -7664.095% |
| Safety Shot Inc | 304.9 Thousand USD | -77191.361% |
| Bright Green Corporation | 201.78 Thousand USD | -116692.183% |
| Embecta Corp. | 1.62 Billion USD | 85.501% |
| ANI Pharmaceuticals, Inc. | 309.66 Million USD | 23.897% |
| Aquestive Therapeutics, Inc. | 91.07 Million USD | -158.758% |
| Collegium Pharmaceutical, Inc. | 489.96 Million USD | 51.901% |
| Dynavax Technologies Corporation | 252.41 Million USD | 6.636% |
| Esperion Therapeutics, Inc. | 501.54 Million USD | 53.012% |
| Intra-Cellular Therapies, Inc. | 13.32 Million USD | -1668.473% |
| Pacira BioSciences, Inc. | 513.79 Million USD | 54.132% |
| PainReform Ltd. | 30 Thousand USD | -785455.903% |
| Sunshine Biopharma, Inc. | 539.03 Thousand USD | -43620.124% |
| Sunshine Biopharma, Inc. | 539.03 Thousand USD | -43620.124% |
| SCYNEXIS, Inc. | 12.15 Million USD | -1838.208% |
| China SXT Pharmaceuticals, Inc. | 117.12 Thousand USD | -201102.752% |
| Journey Medical Corporation | 14.62 Million USD | -1511.727% |
| Alpha Teknova, Inc. | 13.25 Million USD | -1678.483% |
| Procaps Group, S.A. | 28.41 Million USD | -729.52% |
| Theratechnologies Inc. | 51.26 Million USD | -359.739% |
| Harrow Health, Inc. | 183.17 Million USD | -28.659% |
| Sonoma Pharmaceuticals, Inc. | 87 Thousand USD | -270781.346% |
| Biofrontera Inc. | 804 Thousand USD | -29211.787% |
| DURECT Corporation | 2.7 Million USD | -8621.938% |
| Supernus Pharmaceuticals, Inc. | 33.19 Million USD | -609.925% |
| Cronos Group Inc. | 1.55 Million USD | -15016.534% |
| OptiNose, Inc. | 611 Thousand USD | -38470.666% |
| Ironwood Pharmaceuticals, Inc. | 498.3 Million USD | 52.707% |
| Kala Pharmaceuticals, Inc. | 34.19 Million USD | -589.286% |
| RedHill Biopharma Ltd. | 455 Thousand USD | -51694.895% |
| Organogenesis Holdings Inc. | 60.74 Million USD | -287.961% |
| Guardion Health Sciences, Inc. | - USD | -Infinity% |
| Cumberland Pharmaceuticals Inc. | 12.78 Million USD | -1743.43% |
| Radius Health, Inc. | 339.66 Million USD | 30.618% |
| Universe Pharmaceuticals INC | - USD | -Infinity% |
| ProPhase Labs, Inc. | 10.25 Million USD | -2197.395% |
| Phibro Animal Health Corporation | 458.28 Million USD | 48.577% |
| Procaps Group S.A. | 28.41 Million USD | -729.52% |
| Alvotech | 1.02 Billion USD | 77.07% |
| TherapeuticsMD, Inc. | 6.53 Million USD | -3507.881% |
| Viatris Inc. | 16.18 Billion USD | 98.544% |
| Rockwell Medical, Inc. | 8.29 Million USD | -2741.756% |
| Aytu BioPharma, Inc. | 10.87 Million USD | -2066.652% |
| SIGA Technologies, Inc. | 335.99 Thousand USD | -70040.799% |
| Tilray Brands, Inc. | 287.93 Million USD | 18.153% |
| Lifecore Biomedical, Inc. | 120.51 Million USD | -95.558% |
| Shineco, Inc. | 10.01 Million USD | -2252.59% |
| PetIQ, Inc. | 437.82 Million USD | 46.173% |
| Regencell Bioscience Holdings Limited | - USD | -Infinity% |
| Incannex Healthcare Limited | 210 Thousand USD | -112122.272% |
| Neurocrine Biosciences, Inc. | 258.3 Million USD | 8.762% |
| Alimera Sciences, Inc. | 64.48 Million USD | -265.437% |
| Silver Spike Investment Corp. | - USD | -Infinity% |
| Assertio Holdings, Inc. | 38.51 Million USD | -511.899% |
| Shuttle Pharmaceuticals Holdings, Inc. | 135.08 Thousand USD | -174352.969% |
| Petros Pharmaceuticals, Inc. | 6.85 Million USD | -3336.696% |
| Clever Leaves Holdings Inc. | 720 Thousand USD | -32631.496% |
| Cyclo Therapeutics, Inc. | 22.48 Thousand USD | -1048053.225% |
| Avadel Pharmaceuticals plc | 32.75 Million USD | -619.374% |
| Hempacco Co., Inc. | 5.93 Million USD | -3873.474% |
| Talphera, Inc. | - USD | -Infinity% |
| Alvotech | 1.02 Billion USD | 77.07% |
| Eagle Pharmaceuticals, Inc. | 56.21 Million USD | -319.217% |
| Lantheus Holdings, Inc. | 616.12 Million USD | 61.75% |
| Currenc Group, Inc. | 2.5 Million USD | -9300.447% |
| Kamada Ltd. | 7.43 Million USD | -3068.416% |
| Evoke Pharma, Inc. | 5 Million USD | -4613.335% |
| Flora Growth Corp. | 942 Thousand USD | -24917.704% |
| Cyclo Therapeutics, Inc. | 22.48 Thousand USD | -1048053.225% |
| Evolus, Inc. | 120.35 Million USD | -95.803% |
| HUTCHMED (China) Limited | 48.18 Million USD | -389.047% |
| Amphastar Pharmaceuticals, Inc. | 589.19 Million USD | 60.002% |
| Akanda Corp. | 2.49 Million USD | -9337.411% |